Role for p53 in selenium-induced senescence

Journal of Agricultural and Food Chemistry

Volumn 59, Issue 21, 2011, Pages 11882-11887

  Wu, Min ^a   Wu, Ryan T Y ^a   Wang, Thomas T Y ^b   Cheng, Wen Hsing ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

cancer; p53; selenium; senescence

Indexed keywords

ATAXIA-TELANGIECTASIA MUTATED; CANCER; DNA DAMAGES; DNA-DEPENDENT PROTEIN KINASE; G2/M CELL CYCLE ARREST; GALACTOSIDASES; GENOME INSTABILITY; KINASE INHIBITORS; P53; PRE-TREATMENT; SENESCENCE; SENESCENCE INDUCTION; TUMOR SUPPRESSORS;

AUTOMATIC TELLER MACHINES; CELL CULTURE; DNA; ENZYMES; INTERNET PROTOCOLS; SELENIUM;

SELENIUM COMPOUNDS;

PROTEIN P53; SELENIUM;

AGING; ARTICLE; ATAXIA TELANGIECTASIA; CELL CYCLE; DNA DAMAGE; GENETICS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; TUMOR CELL LINE;

AGING; ATAXIA TELANGIECTASIA; CELL CYCLE; CELL LINE, TUMOR; DNA DAMAGE; HUMANS; SELENIUM; TUMOR SUPPRESSOR PROTEIN P53;

ATAXIA TELANGIECTASIA;

EID: 80455173771     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf203012a     Document Type: Article

References (48)

1. Hayflick, L. The limited in vitro lifetime of human diploid cell strains Exp. Cell Res. 1965, 37, 614-636
2. Bartkova, J.; Horejsi, Z.; Koed, K.; Kramer, A.; Tort, F.; Zieger, K.; Guldberg, P.; Sehested, M.; Nesland, J. M.; Lukas, C.; Orntoft, T.; Lukas, J.; Bartek, J. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis Nature 2005, 434, 864-870
3. te Poele, R. H.; Okorokov, A. L.; Jardine, L.; Cummings, J.; Joel, S. P. DNA damage is able to induce senescence in tumor cells in vitro and in vivo Cancer Res. 2002, 62, 1876-1883
4. Bartkova, J.; Rezaei, N.; Liontos, M.; Karakaidos, P.; Kletsas, D.; Issaeva, N.; Vassiliou, L. V.; Kolettas, E.; Niforou, K.; Zoumpourlis, V. C.; Takaoka, M.; Nakagawa, H.; Tort, F.; Fugger, K.; Johansson, F.; Sehested, M.; Andersen, C. L.; Dyrskjot, L.; Orntoft, T.; Lukas, J.; Kittas, C.; Helleday, T.; Halazonetis, T. D.; Bartek, J.; Gorgoulis, V. G. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints Nature 2006, 444, 633-637
5. Di Micco, R.; Fumagalli, M.; Cicalese, A.; Piccinin, S.; Gasparini, P.; Luise, C.; Schurra, C.; Garre, M.; Nuciforo, P. G.; Bensimon, A.; Maestro, R.; Pelicci, P. G.; d'Adda di Fagagna, F. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication Nature 2006, 444, 638-642
6. Bakkenist, C. J.; Kastan, M. B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation Nature 2003, 421, 499-506
7. Guo, Z.; Kozlov, S.; Lavin, M. F.; Person, M. D.; Paull, T. T. ATM activation by oxidative stress Science 2010, 330, 517-521
8. Banin, S.; Moyal, L.; Shieh, S.; Taya, Y.; Anderson, C. W.; Chessa, L.; Smorodinsky, N. I.; Prives, C.; Reiss, Y.; Shiloh, Y.; Ziv, Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage Science 1998, 281, 1674-1677
9. Shieh, S. Y.; Ikeda, M.; Taya, Y.; Prives, C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2 Cell 1997, 91, 325-334
10. Soubeyrand, S.; Schild-Poulter, C.; Hache, R. J. Structured DNA promotes phosphorylation of p53 by DNA-dependent protein kinase at serine 9 and threonine 18 Eur. J. Biochem. 2004, 271, 3776-3784
11. Boehme, K. A.; Kulikov, R.; Blattner, C. p53 stabilization in response to DNA damage requires Akt/PKB and DNA-PK Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 7785-7790
12. Mouchawar, J.; Korch, C.; Byers, T.; Pitts, T. M.; Li, E. F.; McCredie, M. R. E.; Giles, G. G.; Hopper, J. L.; Southey, M. C. Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study Cancer Res. 2010, 70, 4795-4800
13. Seemann, S.; Maurici, D.; Olivier, M.; de Fromentel, C. C.; Hainaut, P. The tumor suppressor gene TP53: implications for cancer management and therapy Crit. Rev. Clin. Lab. Sci. 2004, 41, 551-583
14. Gemignani, F.; Moreno, V.; Landi, S.; Moullan, N.; Chabrier, A.; Gutierrez-Enriquez, S.; Hall, J.; Guino, E.; Peinado, M. A.; Capella, G.; Canzian, F. A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA Oncogene 2004, 23, 1954-1956
15. Mechanic, L. E.; Bowman, E. D.; Welsh, J. A.; Khan, M. A.; Hagiwara, N.; Enewold, L.; Shields, P. G.; Burdette, L.; Chanock, S.; Harris, C. C. Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors Cancer Epidemiol. Biomarkers Prev. 2007, 16, 214-222
16. Ruijs, M. W. G.; Verhoef, S.; Rookus, M. A.; Pruntel, R.; van der Hout, A. H.; Hogervorst, F. B. L.; Kluijt, I.; Sijmons, R. H.; Aalfs, C. M.; Wagner, A.; Ausems, M.; Hoogerbrugge, N.; van Asperen, C. J.; Garcia, E. B. G.; Meijers-Heijboer, H.; ten Kate, L. P.; Menko, F. H.; van't Veer, L. J. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes J. Med. Genet. 2010, 47, 421-428
17. Kaeser, M. D.; Pebernard, S.; Iggo, R. D. Regulation of p53 stability and function in HCT116 colon cancer cells J. Biol. Chem. 2004, 279, 7598-7605
18. Squatrito, M.; Brennan, C. W.; Helmy, K.; Huse, J. T.; Petrini, J. H.; Holland, E. C. Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas Cancer Cell 2010, 18, 619-629
19. Symonds, H.; Krall, L.; Remington, L.; Saenz-Robles, M.; Lowe, S.; Jacks, T.; Van Dyke, T. p53-dependent apoptosis suppresses tumor growth and progression in vivo Cell 1994, 78, 703-711
20. Bocangel, D.; Sengupta, S.; Mitra, S.; Bhakat, K. K. p53-Mediated down-regulation of the human DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) via interaction with Sp1 transcription factor Anticancer Res. 2009, 29, 3741-3750
21. Arias-Lopez, C.; Lazaro-Trueba, I.; Kerr, P.; Lord, C. J.; Dexter, T.; Iravani, M.; Ashworth, A.; Silva, A. p53 modulates homologous recombination by transcriptional regulation of the RAD51 gene EMBO Rep. 2006, 7, 219-224
22. Chen, F.; Chang, D.; Goh, M.; Klibanov, S. A.; Ljungman, M. Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors Cell Growth Differ. 2000, 11, 239-246
23. Bohlig, L.; Friedrich, M.; Engeland, K. p53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins Nucleic Acids Res. 2011, 39, 440-453
24. Sinha, S.; Malonia, S. K.; Mittal, S. P.; Singh, K.; Kadreppa, S.; Kamat, R.; Mukhopadhyaya, R.; Pal, J. K.; Chattopadhyay, S. Coordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MAR element EMBO J. 2010, 29, 830-842
25. Oda, K.; Arakawa, H.; Tanaka, T.; Matsuda, K.; Tanikawa, C.; Mori, T.; Nishimori, H.; Tamai, K.; Tokino, T.; Nakamura, Y.; Taya, Y. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53 Cell 2000, 102, 849-862
26. Mihara, M.; Erster, S.; Zaika, A.; Petrenko, O.; Chittenden, T.; Pancoska, P.; Moll, U. M. p53 has a direct apoptogenic role at the mitochondria Mol. Cell 2003, 11, 577-590
27. Sarveswaran, S.; Liroff, J.; Zhou, Z. X.; Nikitin, A. Y.; Ghosh, J. Selenite triggers rapid transcriptional activation of p53, and p53-mediated apoptosis in prostate cancer cells: Implication for the treatment of early-stage prostate cancer Int. J. Oncol. 2010, 36, 1419-1428
28. Zhao, R.; Xiang, N.; Domann, F. E.; Zhong, W. X. Expression of p53 enhances selenite-induced superoxide production and apoptosis in human prostate cancer cells Cancer Res. 2006, 66, 2296-2304
29. Smith, M. L.; Lancia, J. K.; Mercer, T. I.; Ip, C. Selenium compounds regulate p53 by common and distinctive mechanisms Anticancer Res. 2004, 24, 1401-1408
30. Lippman, S. M.; Klein, E. A.; Goodman, P. J.; Lucia, M. S.; Thompson, I. M.; Ford, L. G.; Parnes, H. L.; Minasian, L. M.; Gaziano, J. M.; Hartline, J. A.; Parsons, J. K.; Bearden, J. D., 3rd; Crawford, E. D.; Goodman, G. E.; Claudio, J.; Winquist, E.; Cook, E. D.; Karp, D. D.; Walther, P.; Lieber, M. M.; Kristal, A. R.; Darke, A. K.; Arnold, K. B.; Ganz, P. A.; Santella, R. M.; Albanes, D.; Taylor, P. R.; Probstfield, J. L.; Jagpal, T. J.; Crowley, J. J.; Meyskens, F. L., Jr.; Baker, L. H.; Coltman, C. A., Jr. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) JAMA-J. Am. Med. Assoc. 2009, 301, 39-51
31. Wu, M.; Kang, M. M.; Schoene, N. W.; Cheng, W. H. Selenium compounds activate early barriers of tumorigenesis J. Biol. Chem. 2010, 285, 12055-12062
32. Qi, Y.; Schoene, N. W.; Lartey, F. M.; Cheng, W. H. Selenium compounds activate ATM-dependent DNA damage response via the mismatch repair protein hMLH1 in colorectal cancer cells J. Biol. Chem. 2010, 285, 33010-33017
33. Zhang, S.; Luo, Y.; Zeng, H.; Wang, Q.; Tian, F.; Song, J.; Cheng, W. H. Encapsulation of selenium in chitosan nanoparticles improves selenium availability and protects cells from selenium-induced DNA damage response. J. Nutr. Biochem. 2011, DOI: 10.1016/j.jnutbio.2010.09.014.
34. Wang, T. T.; Schoene, N. W.; Kim, Y. S.; Mizuno, C. S.; Rimando, A. M. Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells Mol. Nutr. Food Res. 2010, 54, 335-344
35. Cheng, W. H.; von Kobbe, C.; Opresko, P. L.; Arthur, L. M.; Komatsu, K.; Seidman, M. M.; Carney, J. P.; Bohr, V. A. Linkage between Werner syndrome protein and the Mre11 complex via Nbs1 J. Biol. Chem. 2004, 279, 21169-21176
36. Camphausen, K.; Brady, K. J.; Burgan, W. E.; Cerra, M. A.; Russell, J. S.; Bull, E. E. A.; Tofilon, P. J. Flavopiridol enhances human tumor cell radiosensitivity and prolongs expression of γ H2AX foci Mol. Cancer Ther. 2004, 3, 409-416
37. Zhou, X. Z.; Perrem, K.; Lu, K. P. Role of Pin2/TRF1 in telomere maintenance and cell cycle control J. Cell. Biochem. 2003, 89, 19-37
38. Zhou, N.; Xiao, H.; Li, T. K.; Nur, E. K. A.; Liu, L. F. DNA damage-mediated apoptosis induced by selenium compounds J. Biol. Chem. 2003, 278, 29532-29537
39. Zhao, R.; Domann, F. E.; Zhong, W. Apoptosis induced by selenomethionine and methioninase is superoxide mediated and p53 dependent in human prostate cancer cells Mol. Cancer Ther. 2006, 5, 3275-3284
40. Moreno, C. S.; Matyunina, L.; Dickerson, E. B.; Schubert, N.; Bowen, N. J.; Logani, S.; Benigno, B. B.; McDonald, J. F. Evidence that p53-mediated cell-cycle-arrest inhibits chemotherapeutic treatment of ovarian carcinomas PLoS One 2007, 2, e441
41. von Kobbe, C.; May, A.; Grandori, C.; Bohr, V. A. Werner syndrome cells escape hydrogen peroxide-induced cell proliferation arrest FASEB J. 2004, 18, 1970-1972
42. Cheng, W. H.; Muftic, D.; Muftuoglu, M.; Dawut, L.; Morris, C.; Helleday, T.; Shiloh, Y.; Bohr, V. A. WRN is required for ATM activation and the S-phase checkpoint in response to interstrand cross-link-induced DNA double-strand breaks Mol. Biol. Cell 2008, 19, 3923-3933
43. Shiloh, Y. ATM and related protein kinases: safeguarding genome integrity Nat. Rev. Cancer 2003, 3, 155-168
44. Bode, A. M.; Dong, Z. Post-translational modification of p53 in tumorigenesis Nat. Rev. Cancer 2004, 4, 793-805
45. Zeng, H.; Wu, M.; Botnen, J. H. Methylselenol, a selenium metabolite, induces cell cycle arrest in G1 phase and apoptosis via the extracellular- regulated kinase 1/2 pathway and other cancer signaling genes J. Nutr. 2009, 139, 1613-1618
46. Gorgoulis, V. G.; Vassiliou, L. V.; Karakaidos, P.; Zacharatos, P.; Kotsinas, A.; Liloglou, T.; Venere, M.; Ditullio, R. A., Jr.; Kastrinakis, N. G.; Levy, B.; Kletsas, D.; Yoneta, A.; Herlyn, M.; Kittas, C.; Halazonetis, T. D. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions Nature 2005, 434, 907-913
47. di Fagagna, F. D.; Teo, S. H.; Jackson, S. P. Functional links between telomeres and proteins of the DNA-damage response Genes Dev. 2004, 18, 1781-1799
48. Heiss, E. H.; Schilder, Y. D. C.; Dirsch, V. M. Chronic treatment with resveratrol induces redox stress- and ataxia telangiectasia-mutated (ATM)-dependent senescence in p53-positive cancer cells J. Biol. Chem. 2007, 282, 26759-26766